The protein L-isoaspartyl (D-aspartyl) methyltransferase protects against dopamine-induced apoptosis in neuroblastoma SH-SY5Y cells

Neuroscience

Volumn 295, Issue , 2015, Pages 139-150

  Ouazia, D ^a   Levros, L C ^a   Rassart, É ^a   Desrosiers, R R ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Apoptosis; Dopamine; Oxidative stress; Parkinson's disease; PIMT; Protein l isoaspartyl (d aspartyl) methyltransferase

Indexed keywords

CASPASE 3; DOPAMINE; METHYLTRANSFERASE; PROTEIN DEXTRO ASPARTATE METHYLTRANSFERASE; PROTEIN ISOASPARTYL METHYLTRANSFERASE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; CASPASE; PCMT1 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DOPAMINE METABOLISM; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NERVE CELL NECROSIS; NEUROBLASTOMA CELL; NEUROPROTECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; CELL SURVIVAL; DRUG EFFECTS; GENETIC TRANSFECTION; GENETICS; METABOLISM; NEUROBLASTOMA; PATHOLOGY; POINT MUTATION; TUMOR CELL LINE;

APOPTOSIS; CASPASES; CELL LINE, TUMOR; CELL SURVIVAL; DOPAMINE; DOWN-REGULATION; HUMANS; NEUROBLASTOMA; POINT MUTATION; PROTEIN D-ASPARTATE-L-ISOASPARTATE METHYLTRANSFERASE; REACTIVE OXYGEN SPECIES; TRANSFECTION;

EID: 84926431643     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.03.026     Document Type: Article

References (58)

1. Antonini A., Cilia R. Behavioural adverse effects of dopaminergic treatments in Parkinson's disease: incidence, neurobiological basis, management and prevention. Drug Saf 2009, 32:475-488.
2. Billingsley M.L., Balaban C.D. Protein-O-carboxylmethyltransferase in the rat brain: high regional levels in the substantia nigra, locus coeruleus and paraventricular nucleus. Brain Res 1985, 358:96-103.
3. Boland K., Flanagan L., Prehn J.H.M. Paracrine control of tissue regeneration and cell proliferation by Caspase-3. Cell Death Dis 2013, 4:e725.
4. Chan S.W., Lim C.J., Chen L., Chong Y.F., Huang C., Song H., Hong W. The Hippo pathway in biological control and cancer development. J Cell Physiol 2011, 226:928-939.
5. Cimmino A., Capasso R., Muller F., Sambri I., Masella L., Raimo M., De Bonis M.L., D'Angelo S., Zappia V., Galletti P., Ingrosso D. Protein isoaspartate methyltransferase prevents apoptosis induced by oxidative stress in endothelial cells: role of Bcl-Xl deamidation and methylation. PLoS One 2008, 3:e3258.
6. Clarke S. Protein carboxyl methyltransferases: two distinct classes of enzymes. Annu Rev Biochem 1985, 54:479-506.
7. Clarke S. Aging as war between chemical and biochemical processes: protein methylation and the recognition of age-damaged proteins for repair. Ageing Res Rev 2003, 2:263-285.
8. Costantini P., Bruey J.M., Castedo M., Métivier D., Loeffler M., Susin S.A., Ravagnan L., Zamzami N., Garrido C., Kroemer G. Pre-processed caspase-9 contained in mitochondria participates in apoptosis. Cell Death Differ 2002, 9:82-88.
9. Desrosiers R.R., Fanélus I. Damaged proteins bearing l-isoaspartyl residues and aging: a dynamic equilibium between generation of isomerized forms and repair by PIMT. Curr Aging Sci 2011, 4:8-18.
10. Fanélus I., Desrosiers R.R. Reactive oxygen species generated by thiol-modifying phenylarsine oxide stimulate the expression of protein l-isoaspartyl methyltransferase. Biochem Biophys Res Commun 2008, 371:203-208.
11. Fanélus I., Desrosiers R.R. Mitochondrial uncoupler carbonyl cyanide M-chlorophenylhydrazone induces the multimer assembly and activity of repair enzyme protein l-isoaspartyl methyltransferase. J Mol Neurosci 2013, 50:411-423.
12. Farrar C.E., Houser C.R., Clarke S.G. Activation of the PI3K/Akt signal transduction pathway and increased levels of insulin receptor in protein repair-deficient mice. Aging Cell 2005, 4:1-12.
13. Farris S., Giroux M. Deep brain stimulation: a review of the procedure and the complications. JAAPA 2011, 24(39-40):42-45.
14. Guillot S.T., Miller G.W. Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons. Mol Neurobiol 2009, 39:149-170.
15. Hastings T.G. The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson's disease. J Bioenerg Biomembr 2009, 41:469-472.
16. Heman-Ackah S.M., Hallegger M., Rao M.S., Wood M.J.A. RISC in PD: the impact of microRNAs in Parkinson's disease cellular and molecular pathogenesis. Front Mol Neurosci 2013, 6:40.
17. Ingrosso D., D'angelo S., di Carlo E., Perna A.F., Zappia V., Galletti P. Increased methyl esterification of altered aspartyl residues in erythrocyte membrane proteins in response to oxidative stress. Eur J Biochem 2000, 267:4397-4405.
18. Jellinger K.A. Neurobiology of cognitive impairment in Parkinson's disease. Expert Rev Neurother 2012, 12:1451-1466.
19. Johnson B.A., Aswad D.W. Identification and topography of substrates for protein carboxyl methyltransferase in synaptic membrane and myelin-enriched fractions of bovine and rat brain. J Neurochem 1985, 45:1119-1127.
20. Khare S., Gomez T., Linster C.L., Clarke S.G. Defective responses to oxidative stress in protein l-isoaspartyl repair-deficient Caenorhabditis elegans. Mech Ageing Dev 2009, 130:670-680.
21. Klein C., Westenberger A. Genetics of Parkinson's disease. Col Spring Harb Perspect Med 2012, 2:a008888.
22. Koo U., Nam K.W., Ham A., Lyu D., Kim B., Lee S.J., Kim K.H., Oh K.B., Mar W., Shin J. Neuroprotective effects of 3α-acetoxyeudesma-1,4(15),11(13)-trien-12,6α-olide against dopamine-induced apoptosis in the human neuroblastoma SH-SY5Y cell line. Neurochem Res 2011, 36:1991-2001.
23. Korsmeyer S.J. BCL-2 gene family and the regulation of programmed cell death. Cancer Res 1999, 59(7 Suppl.):1693s-1700s.
24. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
25. Lanthier J., Desrosiers R.R. Regulation of protein l-isoaspartyl methyltransferase by cell-matrix interactions: involvement of integrin alphavbeta3, PI 3-kinase, and the proteasome. Biochem Cell Biol 2006, 84:684-694.
26. Lee J.Y., Nagano Y., Taylor J.P., Lim K.L., Yao T.P. Disease-causing mutations in parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy. J Cell Biol 2010, 189:671-679.
27. Lee J.C., Kang S.U., Jeon Y., Park J.W., You J.S., Ha S.W., Bae N., Lubec G., Kwon S.H., Lee J.S., Cho E.J., Han J.W. Protein l-isoaspartyl methyltransferase regulates p53 activity. Nat Commun 2012, 3:927.
28. Li F., Tian X., Zhou Y., Zhu L., Wang B., Ding M., Pang H.J. Dysregulated expression of secretogranin III is involved in neurotoxin-induced dopaminergic neuron apoptosis. Neurosci Res 2012, 90:2237-2246.
29. Li X.L., Li B.Y., Cheng M., Yu F., Yin W.B., Cai Q., Zhang Z., Zhang J.H., Wang J.F., Zhou R.H., Gao H.Q. PIMT prevents the apoptosis of endothelial cells in response to glycated low density lipoproteins and protective effects of grape seed procyanidin B2. PLoS One 2013, 8:e69979.
30. Lotharius J., Brundin P. Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease. Hum Mol Genet 2002, 11:2395-2407.
31. MacKay K.B., Lowenson J.D., Clarke S.G. Wortmannin reduces insulin signaling and death in seizure-prone Pcmt1-/- mice. PLoS One 2012, 7:e46719.
32. Matsuda N., Sato S., Shiba K., Okatsu K., Saisho K., Gautier C.A., Sou Y.S., Saiki S., Kawajiri S., Sato F., Kimura M., Komatsu M., Hattori N., Tanaka K. PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J Cell Biol 2010, 189:211-221.
33. Mizobuchi M., Murao K., Takeda R., Kakimoto Y. Tissue-specific expression of isoaspartyl protein carboxyl methyltransferase gene in rat brain and testis. J Neurochem 1994, 62:322-328.
34. Ouazia D., Levros L.-C., Rassart E., Desrosiers R.R. Dopamine down-regulation of protein l-isoaspartyl methyltransferase is dependent of reactive oxygen species in SH-SY5Y cells. Neuroscience 2014, 267:263-276.
35. Perfeito R., Cunha-Oliveira T., Cristina Rego A. Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson's disease - Resemblance to the effect of amphetamine drugs of abuse. Free Radic Biol Med 2012, 53:1791-1806.
36. Reed J.C. Double identity for proteins of the Bcl-2 family. Nature 1997, 387:773-776.
37. Ross C.A., Poirier M.A. Protein aggregation and neurodegenerative disease. Nat Med 2004, 10(Suppl.):S10-S17.
38. Pišlar A.H., Zidar N., Kikelj D., Kos J. Cathepsin X promotes 6-hydroxydopamine-induced apoptosis of PC12 and SH-SY5Y cells. Neuropharmacology 2014, 82:121-131.
39. Sambri I., Capasso R., Pucci P., Perna A.F., Ingrosso D. The microRNA 15a/16-1 cluster down-regulates protein repair isoaspartyl methyltransferase in hepatoma cells: implications for apoptosis regulation. J Biol Chem 2011, 286:43690-43700.
40. Savitt J.M., Dawson V.L., Dawson T.M. Diagnosis and treatment of Parkinson disease: molecules to medicine. J Clin Invest 2006, 116:1744-1754.
41. Shi Y., Rhodes N.R., Abdolvahabi A., Kohn T., Cook N.P., Marti A.A., Shaw B.F. Deamidation of asparagine to aspartate destabilizes Cu, Zn superoxide dismutase, accelerates fibrillization, and mirrors ALS-linked mutations. J Am Chem Soc 2013, 135:15897-15908.
42. Shih J.C., Chen K., Ridd M.J. Monoamine oxidase: from genes to behavior. Annu Rev Neurosci 1999, 22:197-217.
43. Son J.H., Shim J.H., Kim K.H., Ha J.Y., Han J.Y. Neuronal autophagy and neurodegenerative diseases. Exp Mol Med 2012, 44:89-98.
44. Stroh C., Schulze-Osthoff K. Death by a thousand cuts: an ever increasing list of caspase substrates. Cell Death Differ 1998, 5:997-1000.
45. Surmeier D.J., Guzman J.N., Sanchez J., Schumacker P.T. Physiological phenotype and vulnerability in Parkinson's disease. Cold Spring Harb Perspect Med 2012, 2:a009290.
46. Tatton N.A. Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease. Exp Neurol 2000, 166:29-43.
47. Taylor R.C., Cullen S.P., Martin S.J. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 2008, 9:231-241.
48. Thomas B., Beal M.F. Parkinson's disease. Hum Mol Genet 2007, 16 Spec No. 2:R183-R194.
49. Ura S., Masuyama N., Graves J.D., Gotoh Y. Caspase cleavage of MST1 promotes nuclear translocation and chromatin condensation. Proc Natl Acad Sci U S A 2001, 98:10148-10153.
50. Venderova K., Park D.S. Programmed cell death in Parkinson's disease. Cold Spring Harb Perspect Med 2012, 2:a009365.
51. Verma P., Singh A., Kaur H., Majee M. Protein l-isoaspartyl methyltransferase1 (CaPIMT1) from chickpea mitigates oxidative stress-induced growth inhibition of Escherichia coli. Planta 2010, 231:329-336.
52. Vigneswara V., Lowenson J.D., Powell C.D., Thakur M., Bailey K., Clarke S., Ray D.E., Carter W.G. Proteomic identification of novel substrates of a protein isoaspartyl methyltransferase repair enzyme. J Biol Chem 2006, 281:32619-32629.
53. Viswanath V., Wu Y., Boonplueang R., Chen S., Stevenson F.F., Yantiri F., Yang L., Beal M.F., Andersen J.K. Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease. J Neurosci 2001, 21:9519-9528.
54. Vousden K.H., Prives C. Blinded by the light: the growing complexity of p53. Cell 2009, 137:413-431.
55. Yan G., Qin Q., Yi B., Chuprun K., Sun H., Huang S., Sun J. Protein-l-isoaspartate (d-aspartate) O-methyltransferase protects cardiomyocytes against hypoxia induced apoptosis through inhibiting proapoptotic kinase Mst1. Int J Cardiol 2013, 168:3291-3299.
56. Yang Z., Mo X., Gong Q., Pan Q., Yang X., Cai W., Li C., Ma J.X., He Y., Gao G. Critical effect of VEGF in the process of endothelial cell apoptosis induced by high glucose. Apoptosis 2008, 13:1331-1343.
57. Zheng T.S., Hunot S., Kuida K., Momoi T., Srinivasan A., Nicholson D.W., Lazebnik Y., Flavell R.A. Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation. Nat Med 2000, 6:1241-1247.
58. Zhu J.X., Doyle H.A., Mamula M.J., Aswad D.W. Protein repair in the brain, proteomic analysis of endogenous substrates for protein l-isoaspartyl methyltransferase in mouse brain. J Biol Chem 2006, 281:33802-33813.